[HTML][HTML] ASK1 inhibitor in chronic kidney disease therapy: from bench to bedside
L Wen, Q Wei - Kidney360, 2022 - journals.lww.com
CKD affects a large population of patients worldwide. It is characterized by gradual renal
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
[PDF][PDF] ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside
L Wen, Q Wei - researchgate.net
CKD affects a large population of patients worldwide. It is characterized by gradual renal
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside.
L Wen, Q Wei - Kidney360, 2022 - europepmc.org
CKD affects a large population of patients worldwide. It is characterized by gradual renal
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
[HTML][HTML] ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside
L Wen, Q Wei - Kidney360, 2022 - ncbi.nlm.nih.gov
CKD affects a large population of patients worldwide. It is characterized by gradual renal
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
function loss resulting from persistent renal cell death, chronic inflammation, and fibrosis …
[引用][C] ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside
L Wen, Q Wei - Kidney360, 2022 - augusta.elsevierpure.com
ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside — Augusta
University Research Profiles Skip to main navigation Skip to search Skip to main content …
University Research Profiles Skip to main navigation Skip to search Skip to main content …
[引用][C] ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside
L Wen, Q Wei - Kidney360, 2022 - pubmed.ncbi.nlm.nih.gov
ASK1 Inhibitor in Chronic Kidney Disease Therapy: From Bench to Bedside ASK1 Inhibitor in
Chronic Kidney Disease Therapy: From Bench to Bedside Kidney360. 2022 Jul 28;3(7):1128-1131 …
Chronic Kidney Disease Therapy: From Bench to Bedside Kidney360. 2022 Jul 28;3(7):1128-1131 …